Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Slack     Google Drive     Print     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




sábado, 23 de julio de 2016

ED High-Flow nasal O2 for ARD

The Bottom Line - By Duncan Chambler - 5th July 2016 - Peer-review editor: Steve Mathieu 
Ref. Jones. Respiratory Care 2016; 61(3):291-299. doi:10.4187/respcare.04252 
"Clinical Question 
In hypoxic adults presenting to the emergency department, does nasal high-flow oxygen compared to standard oxygen therapy reduce the need for advanced respiratory support? 
Authors’ Conclusions 
Oxygen therapy delivered by high-flow nasal cannulae did not reduce the need for non-invasive or invasive ventilation when compared against standard oxygen therapy 
However, the trial was unexpectedly underpowered and a true, clinically important benefit may exist, therefore this trial should be considered a pilot for a larger (~900 patient) trial 
One in 12 patients are intolerant of oxygen delivery via high-flow nasal cannulae 
The Bottom Line 
This trial did not demonstrate a difference between nasal high-flow oxygen and standard oxygen therapy in hypoxic and dyspneic patients arriving in the Emergency Department 
Significant weaknesses in the methodology mean that no firm conclusion can be drawn, as a false positive result may have occurred"